Trials / Completed
CompletedNCT07190144
Coronary Flow Reserve Changes After Semaglutide Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 122 (actual)
- Sponsor
- Ekrem Bilal Karaayvaz · Academic / Other
- Sex
- All
- Age
- 28 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about the effects of semaglutide to coronary artery flow in diabetic and non-diabetic patients. The main question it aims to answer is: Does semaglutide enhance coronary artery flow in diabetic and non-diabetic patients? Participants already planned taking semaglutide by an endocrine specialist as their treatment was assessed with CFR before and 3 months after.
Conditions
- The Study Focused on the Vascular Effects of Semaglutide in Both Diabetic and Non-diabetic Patients
- Obesity &Amp; Overweight
Timeline
- Start date
- 2025-01-07
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
- First posted
- 2025-09-24
- Last updated
- 2025-09-24
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07190144. Inclusion in this directory is not an endorsement.